Compositions and methods for implantation of processed adipose tissue and processed adipose tissue products

Abstract

The invention provides compositions and methods for the preparation of processed adipose tissue. The invention further provides methods of use of the processed adipose tissue.

1 .- 29 . (canceled) 
     
     
         30 . An acellular delipidized biocompatible biomaterial comprising a mammalian adipose tissue extracellular matrix (ECM) derived from cadaveric adipose tissue, the biomaterial having between 1% to 0.001% adipose lipid by weight, wherein the biomaterial is non-inflammatory and substantially non-immunogenic when implanted. 
     
     
         31 . The biomaterial of  claim 30 , wherein the adipose tissue is human adipose tissue or porcine adipose tissue. 
     
     
         32 . The biomaterial of  claim 30 , wherein the composition comprises 0.2 μg/mg or less of DNA. 
     
     
         33 . The biomaterial of  claim 30 , further comprising a cross-linking agent. 
     
     
         34 . The biomaterial of  claim 33 , wherein the cross-linking agent is selected from the group consisting of carbodiimide (EDC), hexamethylene diisocyanate (HMDC), gluteraldehyde, proanthocyanidin, ribose, threose, and lysyl oxidase, carbodiimide, polyepoxy ethers, divinyl sulfone (DVS), genipin, polyaldehyde and diphenylphosphoryl azide (DPPA), genipin, epoxy compounds, dialdehyde starch, glutaraldehyde, formaldehyde, dimethyl suberimidate, carbodiimides, succinimidyls, diisocyanates, and acyl azide. 
     
     
         35 . The biomaterial of  claim 30 , wherein the biomaterial is injectable. 
     
     
         36 . The biomaterial of  claim 30 , wherein the biomaterial is sterilized. 
     
     
         37 . A composition comprising at least one biomaterial of  claim 30  and at least one pharmaceutically acceptable carrier or adjuvant. 
     
     
         38 . A method for preparing processed adipose tissue, the method comprising the steps of:
 a. providing mammalian tissue comprising solid adipose;   b. isolating the adipose from the non-adipose material in the tissue; and   c. decellularizing the adipose or extracting lipid from the adipose.   
     
     
         39 . The method of  claim 38 , wherein the decellularizing the adipose or extracting lipid from the adipose comprises manipulating the adipose with a buffer to promote lipid and cell removal to prepare processed adipose tissue. 
     
     
         40 . The method of  claim 39 , wherein the buffer comprises phosphate buffered saline (PBS). 
     
     
         41 . The method of  claim 38 , further wherein the decellularization comprises homogenizing or mincing the tissue. 
     
     
         42 . The method of claim  9 , wherein one or more of a weak acid, non-ionic detergent, or bile acid is used to promote decellurization. 
     
     
         43 . The method of claim  13 , wherein the acid is a weak organized acid. 
     
     
         44 . The method of  claim 38 , wherein the decellularizing the adipose or extracting lipid from the adipose comprises contacting the adipose with a weak acid and a non-ionic detergent. 
     
     
         45 . The method of  claim 38 , wherein decellularizing the adipose or extracting lipid from the adipose comprises contacting the adipose with an acid selected from the group consisting of peracetic acid, acetic acid, boric acid, phosphoric acid, and a bile acid. 
     
     
         46 . The method of  claim 38 , wherein decellularizing the adipose or extracting lipid from the adipose comprises contacting the adipose with a non-ionic detergent selected from the group consisting of ethoxylated fatty alcohol ether, lauryl ethers, ethoxylated alkyl phenols, octylphenoxy polyethoxy ethanol compounds, modified oxyethylated straight-chain alcohols, oxypropylated straight-chain alcohols, polyethylene glycol monooleate compounds, polysorbate compounds, and phenolic fatty alcohol ethers. 
     
     
         47 . The method of  claim 46 , wherein the non-ionic detergent is selected from the group consisting of Triton® X-IOO, Triton® X-114, Pluronics®, Tween® 20, Tween® 80, polyoxyethylated (20) sorbitan monolaurate, Iconol™, Nonidet® P 40 (NP-40), octyl-glucoside, and octyl-thioglucoside. 
     
     
         48 . The method of  claim 38 , wherein the decellularizing the adipose or extracting lipid from the adipose comprises contacting the adipose with supercritical CO 2 . 
     
     
         49 . The method of  claim 38 , wherein the adipose tissue is human adipose tissue or porcine adipose tissue.